Curaleaf — Regulatory Filings 2021

Jan 9, 2021

DLA PIPER

DLA Piper (Canada) LLP Suite 1000, Livingston Place West 250 - 2nd Street SW Calgary, AB T2P 0C1 www.dlapiper.com

DLA Piper (Canada) LLP T 403.296.4470 F 403.296.4474

January 8, 2021

VIA SEDAR

British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Manitoba Securities Commission Ontario Securities Commission New Brunswick Financial and Consumer Services Commission Nova Scotia Securities Commission Office of the Superintendent of Securities, Prince Edward Island Securities NL, Government of Newfoundland and Labrador

Re: Curaleaf Holdings, Inc. Prospectus Supplement dated January 8, 2021

We refer to the prospectus supplement (the "Supplement") of Curaleaf Holdings, Inc. (the "Company") dated January 8, 2021 to the final short form base shelf prospectus of the Company dated November 2, 2020, relating to the sale of subordinate voting shares of the Company.

We hereby consent to the references to our name, DLA Piper (Canada) LLP on the face page and under the heading "Legal Matters" in the Supplement and to the use of our name, DLA Piper (Canada) LLP, and our opinions under the headings "Certain Canadian Federal Income Tax Considerations" and "Eligibility for Investment" in the Supplement, which opinions are provided as of the date of the Supplement.

We confirm that we have read the Supplement and that we have no reason to believe that there are any misrepresentations in the information contained in the Supplement that are derived from our opinions in the Supplement or that are within our knowledge as a result of the services we performed in the preparation of the Supplement.

Sincerely,

(signed) "DLA Piper (Canada) LLP"

112673594